Results 21 to 30 of about 4,417 (197)

In vitro activity of eight antifungal drugs against clinical and hospital isolates of Candida parapsilosis complex; a multicenter study, 2023–2024 [PDF]

open access: yesBMC Infectious Diseases
Background Candida parapsilosis complex is an emerging opportunistic pathogen associated with bloodstream infections and healthcare‑associated outbreaks, particularly in intensive care units.
Azam Moslemi   +13 more
doaj   +2 more sources

546. Transmission of Candida auris FKS1 Mutations in Orange County, CA [PDF]

open access: yesOpen Forum Infect Dis
Background Candida auris (C. auris) is a potentially multidrug-resistant yeast that can cause severe infections in high-risk patient care populations and is endemic in Orange County (OC). U.S.
J. Brown   +11 more
europepmc   +2 more sources

FKS1 mutation associated with decreased echinocandin susceptibility of Aspergillus fumigatus following anidulafungin exposure [PDF]

open access: yesScientific Reports, 2020
Invasive aspergillosis (IA) is a potentially lethal infection that affects mostly immunocompromised patients caused by Aspergillus fumigatus. Echinocandins are a second-line therapy against IA, used as a salvage therapy as well as for empirical or ...
Ana Pinto e Silva   +7 more
semanticscholar   +3 more sources

Caspofungin resistance in Candia auris due to mutations in Fks1 with adjunctive role of chitin and key cell wall stress response pathway genes [PDF]

open access: yesAntimicrobial Agents and Chemotherapy, 2020
The emergence of echinocandin resistance in C. auris has become a major concern. Point mutations in Fks1 subunit of β-D-glucan synthase is the primary mechanism in echinocandin resistance.
Dipti Sharma   +11 more
semanticscholar   +6 more sources

Candida parapsilosis isolates carrying mutations outside of FKS1 hotspot regions confer high echinocandin tolerance and facilitate the development of echinocandin resistance.

open access: yesInternational Journal of Antimicrobial Agents, 2023
Candida parapsilosis is one of the significant causes of candidemia worldwide. Although rare, echinocandin-resistant (ECR) and echinocandin-tolerant (ECT) C. parapsilosis isolates have been reported from various countries.
F. Daneshnia   +10 more
semanticscholar   +4 more sources

Adaptation of the tetracycline-repressible system for modulating the expression of essential genes in Cryptococcus neoformans [PDF]

open access: yesmSphere
The opportunistic human fungal pathogen Cryptococcus neoformans has an enormous impact on human health as the causative agent of cryptococcal meningitis, and there is a dire need to expand our current antifungal arsenal.
Ci Fu, Nicole Robbins, Leah E. Cowen
doaj   +2 more sources

Emergence of multidrug-resistant Candidozyma auris in southern China: a multicenter study on genetic diversity and antifungal resistance [PDF]

open access: yesFrontiers in Microbiology
PurposeCandidozyma auris (C. auris) is an emerging fungal pathogen that is resistant to multiple drugs and poses a serious threat to global health. This study aimed to investigate the genetic diversity and antifungal resistance profiles of C.
Penghao Guo   +9 more
doaj   +2 more sources

Epistasis at the cell surface: what is the role of Erg3 loss-of-function in acquired echinocandin resistance? [PDF]

open access: yesmBio
Echinocandins, which target the fungal β-1,3-glucan synthase (Fks), are essential for treating invasive fungal infections, yet resistance is increasingly reported.
Hans Carolus   +13 more
doaj   +2 more sources

Challenging SNP impact on caspofungin resistance by full-length FKS1 allele replacement in Candida lusitaniae

open access: yesJournal of Antimicrobial Chemotherapy, 2018
OBJECTIVES A strain of the opportunistic pathogenic yeast Candida lusitaniae was genetically engineered for full-length replacement of the FKS1 gene encoding the target of echinocandin antifungals in order to assess the impact of FKS mutations on ...
I. Accoceberry   +4 more
semanticscholar   +3 more sources

In vitro evolution of caspofungin resistance in Candidozyma auris via FKS1 hotspot I mutations results in moderate fitness trade-offs but no reduction in virulence

open access: yesbioRxiv
Resistance to echinocandins in the recently emerged pathogen Candidozyma auris (previously known as Candida auris) poses significant clinical challenges. This study reports the in vitro evolution of a caspofungin-sensitive C.
Ross ZK   +4 more
europepmc   +2 more sources

Home - About - Disclaimer - Privacy